Effectiveness of first-line immune checkpoint blockade versus carboplatin-based chemotherapy for metastatic urothelial cancer

BACKGROUND: Limited data compare first-line carboplatin-based chemotherapy and immune checkpoint blockade in cisplatin-ineligible metastatic urothelial carcinoma (mUC) patients. The primary evidence guiding treatment decisions was a recent Food and Drug Administration/European Medicines Agency safet...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Urol
Main Authors: Feld, Emily, Harton, Joanna, Meropol, Neal J., Adamson, Blythe J.S., Cohen, Aaron, Parikh, Ravi B., Galsky, Matthew D., Narayan, Vivek, Christodouleas, John, Vaughn, David J., Hubbard, Rebecca A., Mamtani, Ronac
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6822167/
https://ncbi.nlm.nih.gov/pubmed/31362898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2019.07.032
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados